Randolph Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Randolph Company's PFE Position: Q3 2019 in Review
Randolph Company sold out of Pfizer (PFE) in Q3 2019, closing a stake of 450,337 shares — an estimated $18.5M sold.
Randolph Company first reported a position in PFE in Q4 2014 and held it in 12 quarters. The position peaked at $18.5M in Q2 2016. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Randolph Company reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
- Randolph Company sold 450,337 Pfizer shares in Q3 2019, an estimated $18.5M.
- Randolph Company first reported a position in Pfizer in Q4 2014 and held it in 12 quarters.
- Randolph Company's Pfizer position peaked at $18.5M in Q2 2016.
- 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Randolph Company's 13F filing for Q3 2019, filed 16 Oct 2019.